Are GLP-1 analogues affordable?
[...]their prescription has generated a cost pressure for West Lothian Community Health and Care Partnership of £280000 with no concomitant drop in insulin costs. Competing interests: DM sits on various prescribing committees in Lothian. 1 Wilding JPH, Hardy K. Glucagon-like peptide-1 analogues for...
Gespeichert in:
| Veröffentlicht in: | BMJ 2011-03, Vol.342 (7797), p.563-563 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Zusammenfassung: | [...]their prescription has generated a cost pressure for West Lothian Community Health and Care Partnership of £280000 with no concomitant drop in insulin costs. Competing interests: DM sits on various prescribing committees in Lothian. 1 Wilding JPH, Hardy K. Glucagon-like peptide-1 analogues for type 2 diabetes. |
|---|---|
| ISSN: | 0959-8138 1468-5833 1756-1833 |
| DOI: | 10.1136/bmj.d1482 |